Announcements Trials
Browse Landscape

Status

Completed 3Withdrawn 2Unknown 1Terminated 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Observational 3

Sponsor

Cancer Type

Other hematologic neoplasm 22Lymphoid 13Breast 9Genitourinary 8Gastrointestinal 8Sarcoma 7Thoracic 6CNS 6Myeloid 5Plasma cell 4Other neoplasm 4Head & Neck 3Dermatologic 3Classical hematology 3Gynecologic 2Other solid neoplasm 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Head and Neck Neoplasms 3

Interventions

Cisplatin 263Radiotherapy 166Cetuximab 158Docetaxel 105Fluorouracil 104pembrolizumab 94Radiotherapy, Intensity-Modulated 83Carboplatin 80Paclitaxel 73Nivolumab 59Erlotinib Hydrochloride 35Surveys and Questionnaires 32Gemcitabine 32durvalumab 29Radiation 29Drug Therapy 25Immunohistochemistry 21Gefitinib 21Capecitabine 21tremelimumab 18Bevacizumab 18Surgical Procedures, Operative 17Sorafenib 17Magnetic Resonance Spectroscopy 17Ipilimumab 17Pemetrexed 16lenvatinib 15atezolizumab 15Radiosurgery 15Gene Expression Profiling 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Microarray Analysis × Head & Neck × Clear all
NCT01466244 2017-05-17

Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397

Eastern Cooperative Oncology Group

Completed
42 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00899340 2013-04-02

Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx

Vanderbilt-Ingram Cancer Center

Completed
54 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00897052 2012-09-10

Gene Expression Profiles in Predicting Survival of Patients With Head and Neck Cancer

Vanderbilt-Ingram Cancer Center

Completed
29 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡